[HTML][HTML] Inhibition of HBV transcription from cccDNA with nitazoxanide by targeting the HBx–DDB1 interaction

K Sekiba, M Otsuka, M Ohno, M Yamagami… - Cellular and molecular …, 2019 - Elsevier
Background & Aims Hepatitis B virus (HBV) infection is a major health concern worldwide.
Although currently used nucleos (t) ide analogs efficiently inhibit viral replication, viral …

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction

K Sekiba, M Otsuka, M Ohno… - Cellular and …, 2019 - pubmed.ncbi.nlm.nih.gov
Background & aims Hepatitis B virus (HBV) infection is a major health concern worldwide.
Although currently used nucleos (t) ide analogs efficiently inhibit viral replication, viral …

[HTML][HTML] Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction

K Sekiba, M Otsuka, M Ohno, M Yamagami… - Cellular and …, 2019 - ncbi.nlm.nih.gov
Methods To identify candidate compounds that target the HBx–DDB1 interaction, a newly
constructed split luciferase assay system was applied to comprehensive compound …

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction

K Sekiba, M Otsuka, M Ohno… - Cellular and …, 2019 - okayama.elsevierpure.com
Background & Aims: Hepatitis B virus (HBV) infection is a major health concern worldwide.
Although currently used nucleos (t) ide analogs efficiently inhibit viral replication, viral …

[HTML][HTML] Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction

K Sekiba, M Otsuka, M Ohno, M Yamagami… - Cellular and …, 2019 - cmghjournal.org
Background & Aims Hepatitis B virus (HBV) infection is a major health concern worldwide.
Although currently used nucleos (t) ide analogs efficiently inhibit viral replication, viral …

[PDF][PDF] Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction

K Sekiba, M Otsuka, M Ohno, M Yamagami… - 2019 - scienceopen.com
We identified nitazoxanide as a novel inhibitor against the hepatitis B virus regulatory
protein X–damage-specific DNA-binding protein 1 interaction via compound screening for …

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction.

K Sekiba, M Otsuka, M Ohno, M Yamagami… - Cellular and …, 2018 - europepmc.org
Methods To identify candidate compounds that target the HBx-DDB1 interaction, a newly
constructed split luciferase assay system was applied to comprehensive compound …

[引用][C] Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction

K Sekiba, M Otsuka, M Ohno, M Yamagami… - Cellular and Molecular …, 2019 - cir.nii.ac.jp
Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1
Interaction | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction

K Sekiba, M Otsuka, M Ohno… - Cellular and …, 2019 - okayama.elsevierpure.com
Background & Aims: Hepatitis B virus (HBV) infection is a major health concern worldwide.
Although currently used nucleos (t) ide analogs efficiently inhibit viral replication, viral …